Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pichler

Showing results (171-180 of 323) with videos related to

Pageof 33
Sort By:
Frontiers in Oncology|March 31, 2023
Optimization of postoperative surveillance protocols in upper tract urothelial cancer: A retrospective cohort studyAndrea Katharina Lindner, Martin Pichler, Sarah Maier, et al.
Journal of Surgical Oncology|October 15, 2013
The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patientsJoanna Szkandera, Martin Pichler, Bernadette Liegl-Atzwanger, et al.
Oncotarget|December 2, 2015
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsChristian Mayr, Andrej Wagner, Magdalena Loeffelberger, et al.
Plos One|February 17, 2017
Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study-Impact for mortalityRainer P Woitas, Hubert Scharnagl, Marcus E Kleber, et al.
Anticancer Research|April 5, 2017
Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer PatientsMichael Stotz, Sereina A Herzog, Martin Pichler, et al.
Clinical Orthopaedics and Related Research|January 14, 2017
Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?Florian Posch, Lukas Leitner, Marko Bergovec, et al.
Cancers|January 16, 2020
Prediction of Postoperative Clinical Outcomes in Resected Stage I Non-Small Cell Lung Cancer Focusing on the Preoperative Glasgow Prognostic ScoreJoerg Lindenmann, Nicole Fink-Neuboeck, Valentin Taucher, et al.
International Journal of Cancer|December 19, 2013
The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomasJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
Clinical Chemistry and Laboratory Medicine|November 13, 2014
The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancerMichael Stotz, Joanna Szkandera, Tatjana Stojakovic, et al.
Anticancer Research|August 9, 2015
3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract CancerChristian Mayr, Andrej Wagner, Angelika Stoecklinger, et al.
Pageof 33

Showing results (171-180 of 323) with videos related to

Sort By:
Pageof 33
Frontiers in Oncology|March 31, 2023
Optimization of postoperative surveillance protocols in upper tract urothelial cancer: A retrospective cohort studyAndrea Katharina Lindner, Martin Pichler, Sarah Maier, et al.
Journal of Surgical Oncology|October 15, 2013
The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patientsJoanna Szkandera, Martin Pichler, Bernadette Liegl-Atzwanger, et al.
Oncotarget|December 2, 2015
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsChristian Mayr, Andrej Wagner, Magdalena Loeffelberger, et al.
Plos One|February 17, 2017
Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study-Impact for mortalityRainer P Woitas, Hubert Scharnagl, Marcus E Kleber, et al.
Anticancer Research|April 5, 2017
Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer PatientsMichael Stotz, Sereina A Herzog, Martin Pichler, et al.
Clinical Orthopaedics and Related Research|January 14, 2017
Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?Florian Posch, Lukas Leitner, Marko Bergovec, et al.
Cancers|January 16, 2020
Prediction of Postoperative Clinical Outcomes in Resected Stage I Non-Small Cell Lung Cancer Focusing on the Preoperative Glasgow Prognostic ScoreJoerg Lindenmann, Nicole Fink-Neuboeck, Valentin Taucher, et al.
International Journal of Cancer|December 19, 2013
The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomasJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
Clinical Chemistry and Laboratory Medicine|November 13, 2014
The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancerMichael Stotz, Joanna Szkandera, Tatjana Stojakovic, et al.
Anticancer Research|August 9, 2015
3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract CancerChristian Mayr, Andrej Wagner, Angelika Stoecklinger, et al.
Pageof 33